5-methoxytryptamine has been researched along with Skin Neoplasms in 2 studies
5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.
Skin Neoplasms: Tumors or cancer of the SKIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, TK | 1 |
| Lin, Z | 1 |
| Tidwell, WJ | 1 |
| Li, W | 1 |
| Slominski, AT | 1 |
| Zuboy, J | 1 |
2 other studies available for 5-methoxytryptamine and Skin Neoplasms
| Article | Year |
|---|---|
Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitro.
Topics: 5-Methoxytryptamine; Adult; Age Factors; Aged; Aged, 80 and over; Black or African American; Cell Pr | 2015 |
Maxamine enhances IL-2 in phase 3 malignant cancer.
Topics: 5-Methoxytryptamine; Clinical Trials, Phase III as Topic; Drug Synergism; Drug Therapy, Combination; | 2000 |